| scholarly article | Q13442814 |
| P50 | author | Daphna Gelblum | Q42290968 |
| Abraham Jing-Ching Wu | Q46139516 | ||
| P2093 | author name string | Zhigang Zhang | |
| Andrew Jackson | |||
| Ellen D Yorke | |||
| Kenneth E Rosenzweig | |||
| Amanda Foster | |||
| Andreas Rimner | |||
| Ankit Modh | |||
| Eric Williams | |||
| Weiji Shi | |||
| Mihir Shah | |||
| P2860 | cites work | Effect of latency on calculated complication rates | Q69619800 |
| Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study | Q80587769 | ||
| A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy | Q82237274 | ||
| Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers | Q83153456 | ||
| Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study | Q83405180 | ||
| Stereotactic body radiotherapy for lung tumors at the pulmonary hilum | Q84146368 | ||
| Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review | Q27012449 | ||
| Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. | Q33532885 | ||
| The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. | Q33532886 | ||
| Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 | ||
| Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model | Q34238364 | ||
| Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
| Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. | Q36084206 | ||
| The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols | Q36608120 | ||
| The use of mixture models for the analysis of survival data with long-term survivors | Q36651475 | ||
| Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer | Q37420376 | ||
| Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial | Q39847699 | ||
| The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy | Q41757810 | ||
| Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group | Q41888159 | ||
| Stereotactic body radiotherapy for central lung tumors | Q44330893 | ||
| Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". | Q51100099 | ||
| Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations. | Q51651716 | ||
| A comprehensive three-dimensional radiation treatment planning system. | Q52553785 | ||
| Non-small cell lung cancer, version 2.2013 | Q59565859 | ||
| Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer | Q59587430 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 1168-1176 | |
| P577 | publication date | 2014-10-08 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy | |
| P478 | volume | 90 |
| Q90144940 | Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? |
| Q91323191 | Comparison of single- and five-fraction schedules of stereotactic body radiation therapy for central lung tumours: a single institution experience |
| Q43191730 | Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy? |
| Q37151785 | Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree |
| Q55021601 | Fiducial marker placement for stereotactic body radiation therapy via convex probe endobronchial ultrasound: a case series and review of literature. |
| Q41678140 | High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer |
| Q89354934 | Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy |
| Q64228382 | Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC |
| Q36235727 | LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective |
| Q61804649 | Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes |
| Q36550894 | Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer |
| Q89924278 | Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors |
| Q48202266 | Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). |
| Q92602008 | Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer |
| Q37643563 | Radiation-induced esophagitis in lung cancer |
| Q30244586 | Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update |
| Q38871523 | Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies |
| Q30241812 | Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review |
| Q61804651 | Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer |
| Q64917835 | Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study. |
| Q90017826 | Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q35734154 | Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy. |
| Q61804650 | The evolving toxicity profile of SBRT for lung cancer |
| Q92807807 | The irregular breathing effect on target volume and coverage for lung stereotactic body radiotherapy |
| Q38930349 | Treatment: Radiation Therapy |
| Q55441971 | [Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer]. |
Search more.